Zafer Bıçakçı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zafer Bıçakçı has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Hayrunnisa Bekis Bozkurt
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL ÜMRANİYE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
3 shared publications - Adalet Meral Güneş
Bursa Uludag University Faculty of Medicine, Division of Pediatric Hematology, Department of Pediatrics, Bursa, Türkiye
1 shared publication - Ali Aycicek
University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Pediatric Hematology and Oncology, İstanbul, Türkiye
1 shared publication - Ali Bülent Antmen
Department of Hematology&Oncology, Acıbadem Adana Hastanesi , Adana, Türkiye
1 shared publication - Ali Fettah
Department of Pediatric Hematology, Etlik City Hospital, Ankara, Türkiye
1 shared publication - Alphan Kupesiz
Division of Hematology, Department of Paediatrics, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Annals of Hematology
Real-world outcomes of children with first relapsed acute lymphoblastic leukemia treated according to the ALL-IC REL 2016 guideline in Türkiye
- 25 September 2026
- Published by Springer Nature in Annals of Hematology
Open AccessReal-world outcomes of children with first relapsed acute lymphoblastic leukemia treated according to the ALL-IC REL 2016 guideline in Türkiye
- Open Access
- 30 April 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (1) , 75-80
Evaluation of Osteoarticular Involvement Associated with Brucellosis in Children
Aim: Brucellosis is a significant public health problem with high morbidity. Its most frequent complication is osteoarticular involvement. The study aimed to evaluate the relationship of osteoarticular involvement with clinical features and prognosis in children with brucellosis. Material and Methods: This retrospective study included pediatric patients between the ages of 1 and 18 years who were hospitalized and diagnosed with brucellosis between 2015 and 2020, and were regularly followed up. and all their findings and osteoarticular involvement data within the last two years were recorded. Clinical features, laboratory findings, osteoarticular involvement, and relapse rates of the patients were evaluated. Results: A total of 80 patients were included study. During the follow-up period, relapse developed in 14 (17.5%) patients. The most commonly affected joints were right (40%, n=32) and left (26.3%, n=21) hips, then right (27.5%, n=22) and left (23.8%, n=19) knees. Shoulder joint involvement rates and C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alanine transaminase (ALT), and aspartate aminotransferase (AST) levels were statistically significantly higher in the relapse group (p=0.016, p=0.003, p=0.001, p
- 30 April 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (1) , 75-80
Open AccessEvaluation of Osteoarticular Involvement Associated with Brucellosis in Children
Aim: Brucellosis is a significant public health problem with high morbidity. Its most frequent complication is osteoarticular involvement. The study aimed to evaluate the relationship of osteoarticular involvement with clinical features and prognosis in children with brucellosis. Material and Methods: This retrospective study included pediatric patients between the ages of 1 and 18 years who were hospitalized and diagnosed with brucellosis between 2015 and 2020, and were regularly followed up. and all their findings and osteoarticular involvement data within the last two years were recorded. Clinical features, laboratory findings, osteoarticular involvement, and relapse rates of the patients were evaluated. Results: A total of 80 patients were included study. During the follow-up period, relapse developed in 14 (17.5%) patients. The most commonly affected joints were right (40%, n=32) and left (26.3%, n=21) hips, then right (27.5%, n=22) and left (23.8%, n=19) knees. Shoulder joint involvement rates and C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alanine transaminase (ALT), and aspartate aminotransferase (AST) levels were statistically significantly higher in the relapse group (p=0.016, p=0.003, p=0.001, p
- Open Access
- 1 January 2025
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 57 (1) , 1-6
A Threat Emerging in Patients with Hematological Malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus Infections
Background: Magnusiomyces capitatus (M. capitatus) and Magnusiomyces clavatus (M. clavatus) are rare cause of fungemia leading to high mortality rates, particularly in neutropenic patients with hematological malignancies. This research set out to explore the clinical characteristics of patients with hematological malignancies with M. capitatus and M. clavatus fungemia. Methods: Eight patients from whom Magnusiomyces spp. were isolated, from among patients hospitalized at the Atatürk University Hospital between October 2017 and November 2022, were enrolled in this retrospective observational study. The 8 patients’ medical data were subjected to analysis. Results: Magnusiomyces capitatus emerged as the pathogen in 5 cases and M. clavatus in 3. The patients’ median age was 35.5 years. The most common underlying hematological malignancy was acute leukemia. Neutrophil values of 500 cells/mm3 were detected in all patients during Magnusiomyces spp. isolation, with severe neutropenia at less than 100 cells/mm3 in 5. The mean duration of neutropenia prior to Magnusiomyces spp. isolation was 29 days. Breakthrough fungemia developed in 7 patients using echinocandins, fluconazole, and posaconazole. Liposomal amphotericin B and voriconazole were used for initial treatment. The general mortality rate was 37%. All isolates were resistant to echinocandins. Voriconazole possessed the lowest minimum inhibitory concentration value against all isolates. The survival rate was higher among young patients. Mortality was higher among patients followed up in the intensive care unit. Conclusion: Life-threatening Magnusiomyces spp. can spread among patients with long-term neutropenia under treatment for hematological malignancies. Awareness and prompt initiation of treatment can reduce the risk of mortality in invasive infections caused by Magnusiomyces spp. Cite this article as: İnan Sarıkaya R, Albayrak A, Erdem F, et al. A threat emerging in patients with hematological malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus infections. Eurasian J Med. 2025; 57(1), 0565, doi: 10.5152/ eurasianjmed.2025.24565.
- 1 January 2025
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 57 (1) , 1-6
Open AccessA Threat Emerging in Patients with Hematological Malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus Infections
Background: Magnusiomyces capitatus (M. capitatus) and Magnusiomyces clavatus (M. clavatus) are rare cause of fungemia leading to high mortality rates, particularly in neutropenic patients with hematological malignancies. This research set out to explore the clinical characteristics of patients with hematological malignancies with M. capitatus and M. clavatus fungemia. Methods: Eight patients from whom Magnusiomyces spp. were isolated, from among patients hospitalized at the Atatürk University Hospital between October 2017 and November 2022, were enrolled in this retrospective observational study. The 8 patients’ medical data were subjected to analysis. Results: Magnusiomyces capitatus emerged as the pathogen in 5 cases and M. clavatus in 3. The patients’ median age was 35.5 years. The most common underlying hematological malignancy was acute leukemia. Neutrophil values of 500 cells/mm3 were detected in all patients during Magnusiomyces spp. isolation, with severe neutropenia at less than 100 cells/mm3 in 5. The mean duration of neutropenia prior to Magnusiomyces spp. isolation was 29 days. Breakthrough fungemia developed in 7 patients using echinocandins, fluconazole, and posaconazole. Liposomal amphotericin B and voriconazole were used for initial treatment. The general mortality rate was 37%. All isolates were resistant to echinocandins. Voriconazole possessed the lowest minimum inhibitory concentration value against all isolates. The survival rate was higher among young patients. Mortality was higher among patients followed up in the intensive care unit. Conclusion: Life-threatening Magnusiomyces spp. can spread among patients with long-term neutropenia under treatment for hematological malignancies. Awareness and prompt initiation of treatment can reduce the risk of mortality in invasive infections caused by Magnusiomyces spp. Cite this article as: İnan Sarıkaya R, Albayrak A, Erdem F, et al. A threat emerging in patients with hematological malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus infections. Eurasian J Med. 2025; 57(1), 0565, doi: 10.5152/ eurasianjmed.2025.24565.
- 23 June 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (2) , 88-95
Use of Gentamicin for Childhood Brucellosis: Effect on Calcium Homeostasis and Relapse
- 23 June 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (2) , 88-95
Use of Gentamicin for Childhood Brucellosis: Effect on Calcium Homeostasis and Relapse
- 23 June 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (2) , 91-98
Use of Gentamicin for Childhood Brucellosis: Effect on Calcium Homeostasis and Relapse
- 23 June 2023
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 17 (2) , 91-98
Use of Gentamicin for Childhood Brucellosis: Effect on Calcium Homeostasis and Relapse
- Open Access
- 1 September 2022
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 14 (1) , e2022070
Congenital Atypical Microcytic Anemia Accompanied by Iron Deficiency and Accumulation
- 1 September 2022
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 14 (1) , e2022070
Open AccessCongenital Atypical Microcytic Anemia Accompanied by Iron Deficiency and Accumulation
- 1 April 2018
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 19 (1) , 79-81
Pseudothrombocytopenia in Case of Acute Viral Hepatitis A
- 1 April 2018
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 19 (1) , 79-81
Pseudothrombocytopenia in Case of Acute Viral Hepatitis A
- 2 January 2017
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 34 (1) , 36-37
False-positive direct antiglobulin test in hematologic malignancies.
- 2 January 2017
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 34 (1) , 36-37
False-positive direct antiglobulin test in hematologic malignancies.
- Open Access
- 1 March 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (9) , e584
Growth Retardation, General Hypotonia, and Loss of Acquired Neuromotor Skills in the Infants of Mothers With Cobalamin Deficiency and the Possible Role of Succinyl-CoA and Glycine in the Pathogenesis
Vitamin B12 (cobalamin, Cbl) deficiency can cause metabolic, hematological, and neurological abnormalities. Adequate levels of succinyl-coenzyme A (CoA) cannot be synthesized from methylmalonyl-CoA because of the decreased activity of the methylmalonyl-CoA mutase enzyme that uses Cbl as the cofactor. Succinyl-CoA synthesis deficiency leads to decreased heme synthesis and gluconeogenesis. The reason of growth retardation can be gluconeogenesis deficiency together with heme synthesis deficiency whereas the reason of the neurological abnormalities can be glycine increase in the tissue due to decreased heme synthesis. We present 7 infants diagnosed with severe nutritional Cbl deficiency and discuss the role of succinyl-CoA and glycine in the possible pathogenesis in this article. Patients brought to our clinic with a complaint of growth retardation and diagnosed with nutritional Cbl deficiency were included in the study. There were 5 females and 2 males. The mean age was 11 ± 2.30 (range 6–13) months. All patients had general muscular hypotonia and 4 had growth retardation. Neuromotor growth retardation was found in 4 of the children who had previously shown normal neuromotor development for age. The mean Cbl level was 83.8 ± 27.6 (45.6–114) pg/mL. The mean Cbl level of the mothers was 155 ± 56.6 (88–258) pg/mL. Six of the patients had anemia and 1 had thrombocytopenia. Mean corpuscular volume value was 91.5 ± 12.2 fL. Following treatment, the muscle tonus of the patients improved, the anemia and growth retardation decreased, and the lost neuromotor abilities were recovered. Severe nutritional Cbl deficiency is an important nutritional disease where complications can be prevented with early treatment. When evaluating the pathogenesis, it should be noted that nutritional Cbl deficiency is a succinyl-CoA synthesis deficiency.
- 1 March 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (9) , e584
Open AccessGrowth Retardation, General Hypotonia, and Loss of Acquired Neuromotor Skills in the Infants of Mothers With Cobalamin Deficiency and the Possible Role of Succinyl-CoA and Glycine in the Pathogenesis
Vitamin B12 (cobalamin, Cbl) deficiency can cause metabolic, hematological, and neurological abnormalities. Adequate levels of succinyl-coenzyme A (CoA) cannot be synthesized from methylmalonyl-CoA because of the decreased activity of the methylmalonyl-CoA mutase enzyme that uses Cbl as the cofactor. Succinyl-CoA synthesis deficiency leads to decreased heme synthesis and gluconeogenesis. The reason of growth retardation can be gluconeogenesis deficiency together with heme synthesis deficiency whereas the reason of the neurological abnormalities can be glycine increase in the tissue due to decreased heme synthesis. We present 7 infants diagnosed with severe nutritional Cbl deficiency and discuss the role of succinyl-CoA and glycine in the possible pathogenesis in this article. Patients brought to our clinic with a complaint of growth retardation and diagnosed with nutritional Cbl deficiency were included in the study. There were 5 females and 2 males. The mean age was 11 ± 2.30 (range 6–13) months. All patients had general muscular hypotonia and 4 had growth retardation. Neuromotor growth retardation was found in 4 of the children who had previously shown normal neuromotor development for age. The mean Cbl level was 83.8 ± 27.6 (45.6–114) pg/mL. The mean Cbl level of the mothers was 155 ± 56.6 (88–258) pg/mL. Six of the patients had anemia and 1 had thrombocytopenia. Mean corpuscular volume value was 91.5 ± 12.2 fL. Following treatment, the muscle tonus of the patients improved, the anemia and growth retardation decreased, and the lost neuromotor abilities were recovered. Severe nutritional Cbl deficiency is an important nutritional disease where complications can be prevented with early treatment. When evaluating the pathogenesis, it should be noted that nutritional Cbl deficiency is a succinyl-CoA synthesis deficiency.